{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Completed",
      "city": "Orlando",
      "state": "FL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "90204",
      "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy",
      "address_1": "6700 Conroy Rd Ste 155",
      "address_2": "",
      "postal_code": "32835-3515",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands",
      "recall_number": "D-0902-2022",
      "product_description": "Sermorelin Acetate Lyophilized powder for reconstitution 9 mg Per Multi-Dose Vial, Rx Only,  Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835, NDC 73198-0059-00",
      "product_quantity": "4459 vials",
      "reason_for_recall": "Lack of assurance of sterility.",
      "recall_initiation_date": "20220509",
      "center_classification_date": "20220525",
      "report_date": "20220601",
      "code_info": "Lots: L24115 BUD: 12/15/2022; A24203 BUD: 01/03/2023; A24106 BUD: 01/06/2023",
      "more_code_info": ""
    }
  ]
}